Drug Delivery Devices are used for administration of drug compounds in effective ways. Implantable ports, also called portacaths or subcutaneous ports, are used to administer chemotherapy, medicine, fluids, and nutrients, or take blood samples. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable ports devices market, including market shares of different players within India. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the implantable ports market in India was CR Bard followed by AngioDynamics, B. Braun Melsungen, Teleflex and Vygon.
An Implantable Port consists of a catheter with a small reservoir (port) attached to it. Implantable Ports covers both Double Lumen and Single Lumen Implantable Ports. A Double Lumen Port is a port with two access points. A Single Lumen Port is a port with one access point.
The value of the implantable ports devices market within India was expected to be over $0.5m in 2023.
For the latest complete market share analysis of implantable ports device market in India, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.